Deal facts
- Buyer
- Live Oak Health LLC
- Target
- Adia Labs LLC
- Deal value
- USD 1,500,000
- Announced
- 6 October 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash, loan-note
Sources
Live Oak Health LLC has agreed to acquire a minority stake in Adia Labs LLC. The transaction, which was completed on 30 September 2026, involved a total equity value of 1.5 million US dollars. The consideration for this healthcare sector deal consisted of a combination of cash and a loan note. Both the buyer and the target are based in the United States. The announcement of the deal was made on 6 October 2026, shortly after the completion date. This investment represents a strategic entry for Live Oak Health into the Adia Labs business structure. The specific terms regarding the percentage of equity acquired were not detailed in the available data. The deal structure allows for a flexible financial arrangement through the inclusion of debt instruments alongside immediate cash payment. This type of minority investment is common in the healthcare industry for fostering growth without full consolidation. The parties have finalised all necessary agreements to facilitate the transfer of ownership interests. The transaction reflects a standard approach to corporate expansion in the US market. No further regulatory hurdles are indicated as the deal is already concluded. The status of the transaction is recorded as completed.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Live Oak Health LLC completes acquisition of Adia Labs LLC
Item 1.01. Entry into a Material Definitive Agreement On September 30, 2026, Adia Med, Inc. (the “Company”), Adia Labs LLC, a Florida limited liability company and subsidiary of the Company (the “Labs Company”), and Live Oak Health LLC, a Florida limited liability company doing business as QCM Biologics (“Buyer”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”). Da
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Creative Medical Technology Holdings, Inc. to acquire BioDefense, Inc.
Creative Medical Technology Holdings, Inc. has agreed to acquire a minority stake in BioDefense, Inc. The transaction was announced on 25 September 2026 and completed on…
- Buyer
- Creative Medical Technology Holdings, Inc.
- Target
- BioDefense, Inc.
- Deal value
- Not disclosed
- Deal type
- minority stake
company owned by Luis Collantes to acquire Creo Medical SL
A company owned by Luis Collantes has agreed to acquire a minority stake in Creo Medical SL, a healthcare business based in Spain. The transaction involves cash consider…
- Buyer
- company owned by Luis Collantes
- Target
- Creo Medical SL
- Deal value
- Not disclosed
- Deal type
- minority stake
YA II PN, LTD to acquire JUPITER NEUROSCIENCES, INC.
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
- Buyer
- YA II PN, LTD
- Target
- JUPITER NEUROSCIENCES, INC.
- Deal value
- USD 1,860,000
- Deal type
- minority stake
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Buyer history
Live Oak Health LLC
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive